Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.

Transplantation - 27 Apr 2013

Gracia-Ahufinger Irene, Gutiérrez-Aroca Juan, Cordero Elisa, Vidal Elisa, Cantisán Sara, del Castillo Domingo, Martín-Gandul Cecilia, Rivero Antonio, Torre-Cisneros Julián

Abstract excerpt

BACKGROUND: Experience with high-dose ganciclovir for the management of resistant cytomegalovirus (CMV) replication in transplant patients is limited despite its adoption as an effective therapy by some consensus documents. METHODS: We studied six cases of CMV replication in solid organ transplan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus
Share to Cytomegalovirus Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Ganciclovir

Share to Genes, Viral

Share to Organ Transplantation

Share to Viral Load

Share to Virus Replication

Source

Identifiers

PMID: 23407543
DOI: 10.1097/TP.0b013e31828555ac

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-23407543-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.PMID 23407543Read ↗

Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.Semantic proximity Read ↗

A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.Semantic proximity Read ↗

Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.Semantic proximity Read ↗

Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance.Semantic proximity Read ↗

Evaluation of ganciclovir resistance in cytomegalovirus infection of renal transplant recipients in Tehran.Semantic proximity Read ↗

Molecular Analysis of Ganciclovir-Resistant Cytomegalovirus in Renal Transplant Recipients with High Viral Load.Semantic proximity Read ↗

[Ganciclovir treatment failure in adult allogeneic hematopoietic stem cell transplant recipients with cytomegalovirus infection--a single centre experience].Semantic proximity Read ↗

Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.Semantic proximity Read ↗

Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.Semantic proximity Read ↗

Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.Semantic proximity Read ↗

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.Semantic proximity Read ↗

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.